UPL delivered strong Q1FY27 results, with revenue up 10% YoY to ₹10,181 Cr and EBITDA growing 15% YoY to ₹1,500 Cr. Profit after tax (PATMI) significantly improved to ₹10 Cr from a loss last year, marking the seventh consecutive quarter of margin expansion. Growth was broad-based, led by India and the Americas, with Advanta (seeds) and SUPERFORM (specialty chemicals) showing robust performance.
UPL's strategy focuses on simplifying operations, improving earnings quality, driving profitable growth, and strengthening financials through deleveraging. Recent highlights include a ratings upgrade to CARE AA+ (Stable), progress on crop protection business reorganization, and the Advanta IPO process remaining on track. UPL also maintained its FTSE4Good ESG index inclusion.
Key financial metrics include Net Debt/EBITDA improving to 2.4x (from 2.6x YoY), reflecting disciplined capital management. For FY27, UPL guides for 7-11% revenue growth and 10-14% EBITDA growth, prioritizing margins, PATMI, deleveraging, and returns.